Neutral Zensar Technologies Ltd For Target Rs. 770 by Motilal Oswal Financial Services Ltd

* We expect a decline of 0.5% QoQ CC in 4QFY25.
* We anticipate EBITDA margins to improve by 20bp QoQ to 15.7%. The company is likely to exit FY25 in its guided range of mid-teen EBITDA margins.
* The demand environment in healthcare and life sciences segment remains soft. A significant portion of order book can be concentrated in BFSI and Europe.
* Commentary on the deal pipeline, discretionary spending, and client pyramid—given the company's focus on farming efforts—will be key to monitor.
For More Research Reports : Click Here
For More Motilal Oswal Securities Ltd Disclaimer
http://www.motilaloswal.com/MOSLdisclaimer/disclaimer.html
SEBI Registration number is INH000000412









